| Autor: |
Kaur A; Albert Einstein College of Medicine, Jacobi Medical Center, New York, United States of America. Electronic address: dr.anahatkaur@gmail.com., Streck B; Cancer and Aging Research Group, USA., Pergolotti M; ReVital Cancer Rehabilitation, Select Medical, USA., Battisti NML; The Royal Marsden NHS Foundation Trust, Department of Medicine, UK., Krok-Schoen JL; School of Health and Rehabilitation Sciences, Ohio State University, USA., Cabrera Chien L; City of Hope Comprehensive Cancer Center, California, USA., Canin B; Cancer and Aging Research Group, USA., Ali I; Icahn School of Medicine, Mount Sinai, New York, USA., Malone MV; Florida Cancer Specialists and Research Institute, Venice, Florida, USA., MacKenzie A; Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Shahrokni A; Jersey Shore University Medical Center, New Jersey, USA., Plotkin E; Association of Community Cancer Centers, USA., Boehmer LB; Association of Community Cancer Centers, USA., BrintzenhofeSzoc K; Kent School of Social Work and Family Science, University of Louisville, Kentucky, USA. |
| Abstrakt: |
Competing Interests: Declaration of Competing Interest NMLB declares the following conflicts of interest: Advisory board: Pfizer, Abbott, Sanofi, Astellas; travel grants: Exact Sciences, Pfizer, Lilly, Novartis; speaker fees: Pfizer, AbbVie, Roche, Sanofi, Novartis, Servier, Gilead, Astrazeneca. The other authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest. Survey respondents participated in the study voluntarily and acknowledged that results may be reported in multiple publications. University of Cincinnati's IRB approved both studies. The University of Louisville IRB approved the 2021 study. This project was supported in part by the grant No. P30 CA008748 from the National Institute of Health, United states. |
Full Text from ScienceDirect